Company
Following A -10.81% Weekly Decline, Is It Still A Buy For Nautilus Biotechnology Inc (NASDAQ: NAUT)?
Nautilus Biotechnology Inc (NASDAQ:NAUT)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 1.14. At the close of
